NCT00005803 2020-01-29
Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma
Fred Hutchinson Cancer Center
Phase 1/2 Completed
Clinical Trials
1 trialsPhase 1/2 × Leukemia, Prolymphocytic, T-Cell × carmustine, poliferprosan 20 drug combination × Clear all